BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 21904393)

  • 1. Incorporating life expectancy in glaucoma care.
    Wesselink C; Stoutenbeek R; Jansonius NM
    Eye (Lond); 2011 Dec; 25(12):1575-80. PubMed ID: 21904393
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk of perimetric blindness among juvenile glaucoma patients.
    Gupta V; Devi K S; Kumar S; Pandey RM; Sihota R; Sharma A; Gupta S
    Ophthalmic Physiol Opt; 2015 Mar; 35(2):206-11. PubMed ID: 25664420
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prior rates of visual field loss and lifetime risk of blindness in glaucomatous patients undergoing trabeculectomy.
    Foulsham WS; Fu L; Tatham AJ
    Eye (Lond); 2015 Oct; 29(10):1353-9. PubMed ID: 26315699
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Measurement of glaucoma-specific functionality with the GQL-15 and correlation with parameters of visual function].
    Hirneiss C; Vogel M; Kampik A; Neubauer AS; Kernt M
    Ophthalmologe; 2011 Oct; 108(10):939-46. PubMed ID: 21779960
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tolerable rates of visual field progression in a population-based sample of patients with glaucoma.
    Salonikiou A; Founti P; Kilintzis V; Antoniadis A; Anastasopoulos E; Pappas T; Raptou A; Topouzis F
    Br J Ophthalmol; 2018 Jul; 102(7):916-921. PubMed ID: 28972029
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A visual field index for calculation of glaucoma rate of progression.
    Bengtsson B; Heijl A
    Am J Ophthalmol; 2008 Feb; 145(2):343-53. PubMed ID: 18078852
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Baseline Age and Mean Deviation Affect the Rate of Glaucomatous Vision Loss.
    Bommakanti N; De Moraes CG; Boland MV; Myers JS; Wellik SR; Elze T; Pasquale LR; Shen LQ; Ritch R; Liebmann JM
    J Glaucoma; 2020 Jan; 29(1):31-38. PubMed ID: 31688371
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is poor life expectancy a predictive factor in the progression of primary open angle glaucoma?
    Tattersall CL; Vernon SA; Negi A
    Eye (Lond); 2005 Apr; 19(4):387-91. PubMed ID: 15309025
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Performance of the visual field index in glaucoma patients with moderately advanced visual field loss.
    Lee JM; Cirineo N; Ramanathan M; Nouri-Mahdavi K; Morales E; Coleman AL; Caprioli J
    Am J Ophthalmol; 2014 Jan; 157(1):39-43. PubMed ID: 24200229
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors and long term progression in open angle glaucoma patients.
    Pantalon AD; Feraru C; Chiseliţă D
    Rom J Ophthalmol; 2016; 60(3):174-180. PubMed ID: 29450344
    [No Abstract]   [Full Text] [Related]  

  • 11. Glaucoma monitoring in a clinical setting: glaucoma progression analysis vs nonparametric progression analysis in the Groningen Longitudinal Glaucoma Study.
    Wesselink C; Heeg GP; Jansonius NM
    Arch Ophthalmol; 2009 Mar; 127(3):270-4. PubMed ID: 19273789
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk Factors for Fast Visual Field Progression in Glaucoma.
    Kim JH; Rabiolo A; Morales E; Yu F; Afifi AA; Nouri-Mahdavi K; Caprioli J
    Am J Ophthalmol; 2019 Nov; 207():268-278. PubMed ID: 31238025
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors affecting rates of visual field progression in glaucoma patients with optic disc hemorrhage.
    Prata TS; De Moraes CG; Teng CC; Tello C; Ritch R; Liebmann JM
    Ophthalmology; 2010 Jan; 117(1):24-9. PubMed ID: 19896197
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Measuring Rates of Visual Field Progression in Linear Versus Nonlinear Scales: Implications for Understanding the Relationship Between Baseline Damage and Target Rates of Glaucoma Progression.
    Liebmann K; De Moraes CG; Liebmann JM
    J Glaucoma; 2017 Aug; 26(8):721-725. PubMed ID: 28692594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Personalized Prediction of Glaucoma Progression Under Different Target Intraocular Pressure Levels Using Filtered Forecasting Methods.
    Kazemian P; Lavieri MS; Van Oyen MP; Andrews C; Stein JD
    Ophthalmology; 2018 Apr; 125(4):569-577. PubMed ID: 29203067
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Natural history of open-angle glaucoma.
    Heijl A; Bengtsson B; Hyman L; Leske MC;
    Ophthalmology; 2009 Dec; 116(12):2271-6. PubMed ID: 19854514
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of focal lamina cribrosa defect on glaucomatous visual field progression.
    Faridi OS; Park SC; Kabadi R; Su D; De Moraes CG; Liebmann JM; Ritch R
    Ophthalmology; 2014 Aug; 121(8):1524-30. PubMed ID: 24697910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of visual field progression in glaucoma.
    Fitzke FW; Hitchings RA; Poinoosawmy D; McNaught AI; Crabb DP
    Br J Ophthalmol; 1996 Jan; 80(1):40-8. PubMed ID: 8664231
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new index to monitor central visual field progression in glaucoma.
    de Moraes CG; Furlanetto RL; Ritch R; Liebmann JM
    Ophthalmology; 2014 Aug; 121(8):1531-8. PubMed ID: 24726202
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combining optical coherence tomography with visual field data to rapidly detect disease progression in glaucoma: a diagnostic accuracy study.
    Garway-Heath DF; Zhu H; Cheng Q; Morgan K; Frost C; Crabb DP; Ho TA; Agiomyrgiannakis Y
    Health Technol Assess; 2018 Jan; 22(4):1-106. PubMed ID: 29384083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.